Acacia Pharma Group PLC is a biopharmaceutical company that focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures, or chemotherapy. Its product portfolio includes BARHEMSYS, BYFAVO, and APD403.
Quote | Atacama Pacific Gold Corp (OTCMKTS:ACPGF)
Last: | $0.99 |
---|---|
Change Percent: | 0.0% |
Open: | $0.99 |
Close: | $0.99 |
High: | $0.99 |
Low: | $0.99 |
Volume: | 385 |
Last Trade Date Time: | 06/10/2022 04:51:51 pm |
News | Atacama Pacific Gold Corp (OTCMKTS:ACPGF)
Eagle Pharmaceuticals (NASDAQ:EGRX) is acquiring U.K.-based Acacia Pharma Group (OTCPK:ACPGF). The terms of the proposed transaction value Acacia’s existing issued and to be issued share capital at ~€94.7M, or €0.90 per share. Eagle will pay ~€71.6M in cash and the...
Message Board Posts | Atacama Pacific Gold Corp (OTCMKTS:ACPGF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Atacama Pacific Gold Corp Company Name:
ACPGF Stock Symbol:
OTCMKTS Market:
Atacama Pacific Gold Corp Website: